NewsBenzingaIonis Pharmaceuticals: el BPA ajustado del tercer trimestre de $(0.40) supera la estimación de $(1.21); las ventas de $243.000 millones superan la estimación de $182.117 millones Ionis Pharmaceuticals: el BPA ajustado del tercer trimestre de $(0.40) supera la estimación de $(1.21); las ventas de $243.000 millones superan la estimación de $182.117 millones Benzinga 2026.11.09 12:04 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares